Andrew D. Yeoman
- Hepatology top 1%
- Liver Disease and Transplantation 21
- Liver Diseases and Immunity 8
- Hepatitis C virus research 3
- Epidemiology top 5%
- Liver Disease Diagnosis and Treatment 21
- Pharmacology top 10%
-
- Alcohol Consumption and Health Effects 3
-
- Renal function and acid-base balance 3
-
- Gallbladder and Bile Duct Disorders 3
-
- Colorectal Cancer Screening and Detection 2
- Co-authors
- Julia WendonR.D. AbelesJohn DillonGeorg AuzingerNicholas TaylorWilliam BernalDebbie L. ShawcrossMichael A. Heneghan
- Cited by
- HepatologyEpidemiologyPharmacology
- Partner nations
- United KingdomUnited StatesAustralia
In The Last Decade
Andrew D. Yeoman
27 papers receiving 976 citations
Hit Papers
Peers
Comparison fields: 5 of 94
- Hepatology 622
- Epidemiology 653
- Pharmacology 74
- Surgery 252
- Pathology and Forensic Medicine 95
Countries citing papers authored by Andrew D. Yeoman
This map shows the geographic impact of Andrew D. Yeoman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew D. Yeoman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew D. Yeoman more than expected).
Fields of papers citing papers by Andrew D. Yeoman
This network shows the impact of papers produced by Andrew D. Yeoman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew D. Yeoman. The network helps show where Andrew D. Yeoman may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Andrew D. Yeoman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2026 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 10 | |
| 4 | 2023 | 4 | |
| 5 | 2023 | 4 | |
| 6 | 2023 | 4 | |
| 7 | 2023 | 3 | |
| 8 | 2022 | 3 | |
| 9 | 2022 | 0 | |
| 10 | 2022 | 26 | |
| 11 | Guidelines on the management of abnormal liver blood testsbreakdown → | 2017 | 340 |
| 12 | 2014 | 1 | |
| 13 | 2014 | 1 | |
| 14 | 2012 | 47 | |
| 15 | 2011 | 68 | |
| 16 | 2010 | 198 | |
| 17 | 2010 | 90 | |
| 18 | AN EVALUATION OF MORTALITY IN ADULTS AND CHILDREN WHO HAVE SURVIVED IN EXCESS OF 5 AND 10 YEARS SINCE LIVER TRANSPLANTATION | 2009 | 1 |
| 19 | A survey of colonoscopy capacity in New Zealand's public hospitals. | 2007 | 12 |
| 20 | Hyperplastic polyposis in the New Zealand population: a condition associated with increased colorectal cancer risk and European ancestry. | 2007 | 29 |
About Andrew D. Yeoman
Andrew D. Yeoman is a scholar working on Hepatology, Epidemiology and Nephrology, having authored 31 papers that have together received 1.0k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (21 papers), Liver Disease and Transplantation (21 papers), Liver Diseases and Immunity (8 papers), Renal function and acid-base balance (3 papers), Alcohol Consumption and Health Effects (3 papers), Gallbladder and Bile Duct Disorders (3 papers), Hepatitis C virus research (3 papers) and Colorectal Cancer Screening and Detection (2 papers). The work is most often cited by research in Hepatology (622 citations), Epidemiology (653 citations) and Pharmacology (74 citations). Andrew D. Yeoman has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Julia Wendon, R.D. Abeles, John Dillon, Georg Auzinger, Nicholas Taylor, William Bernal, Debbie L. Shawcross, Michael A. Heneghan, John Devlin and John G. O’Grady. Their work appears in journals such as Hepatology, Gut and Journal of Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.